IO Biotech (IOBT) News Today $1.48 -0.01 (-0.67%) As of 10:00 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IOBT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period IOBT IO Biotech, Inc. - Seeking AlphaJune 29, 2025 | seekingalpha.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest Down 35.0% in MayJune 17, 2025 | marketbeat.comWall Street Zen Upgrades IO Biotech (NASDAQ:IOBT) to "Sell"June 14, 2025 | marketbeat.comCitadel Advisors LLC Purchases Shares of 270,504 IO Biotech, Inc. (NASDAQ:IOBT)June 7, 2025 | marketbeat.comIO Biotech Regains Nasdaq Compliance with Stock PriceJune 4, 2025 | msn.comIO Biotech, Inc. (NASDAQ:IOBT) Director Acquires $20,850.00 in StockJune 3, 2025 | insidertrades.comIO Biotech, Inc. (NASDAQ:IOBT) Sees Large Growth in Short InterestJune 2, 2025 | marketbeat.comHeidi Hunter Buys 15,000 Shares of IO Biotech, Inc. (NASDAQ:IOBT) StockJune 2, 2025 | marketbeat.comIO Biotech files for the sale of up to 5.6M shares of common stock for holdersMay 23, 2025 | msn.comIO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare ConferenceMay 20, 2025 | globenewswire.comQ2 Earnings Forecast for IO Biotech Issued By HC WainwrightMay 20, 2025 | marketbeat.comIO Biotech price target raised to $14 from $12 at H.C. WainwrightMay 15, 2025 | finance.yahoo.comIO Biotech Reports First Quarter 2025 Financial Results and Business HighlightsMay 14, 2025 | globenewswire.comIO Biotech (IOBT) Expected to Announce Quarterly Earnings on TuesdayMay 8, 2025 | marketbeat.comIO Biotech unveils promising vaccine preclinical dataApril 27, 2025 | investing.comIO Biotech Presents New Preclinical Data Supporting Dual-Antigen and TGF-β-Directed Vaccines for Enhancing Anti-Tumor Immunity at AACR 2025April 27, 2025 | nasdaq.comIO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025April 26, 2025 | globenewswire.comDauntless Investment Group LLC Acquires Shares of 747,646 IO Biotech, Inc. (NASDAQ:IOBT)April 26, 2025 | marketbeat.comIO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170April 25, 2025 | globenewswire.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest Up 156.6% in MarchApril 17, 2025 | marketbeat.comWe're A Little Worried About IO Biotech's (NASDAQ:IOBT) Cash Burn RateApril 12, 2025 | finance.yahoo.comLandscape Capital Management L.L.C. Purchases Shares of 442,196 IO Biotech, Inc. (NASDAQ:IOBT)April 10, 2025 | marketbeat.comQ1 Earnings Estimate for IO Biotech Issued By HC WainwrightApril 6, 2025 | marketbeat.comPiper Sandler Sticks to Their Buy Rating for IO Biotech (IOBT)April 2, 2025 | markets.businessinsider.comIO Biotech (NASDAQ:IOBT) Receives "Buy" Rating from HC WainwrightApril 2, 2025 | marketbeat.comShort Interest in IO Biotech, Inc. (NASDAQ:IOBT) Increases By 54.8%March 31, 2025 | marketbeat.comIO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual MeetingMarch 25, 2025 | globenewswire.comIO Biotech Named Among Fast Company’s World’s Most Innovative Companies of 2025March 18, 2025 | finance.yahoo.comIO Biotech Named Among Fast Company's World's Most Innovative Companies of 2025March 18, 2025 | globenewswire.comShort Interest in IO Biotech, Inc. (NASDAQ:IOBT) Increases By 32.9%March 17, 2025 | marketbeat.comIO Biotech (NASDAQ:IOBT) Upgraded at Piper SandlerMarch 15, 2025 | marketbeat.comPiper Sandler Keeps Their Buy Rating on IO Biotech (IOBT)March 12, 2025 | markets.businessinsider.comHC Wainwright Reaffirms "Buy" Rating for IO Biotech (NASDAQ:IOBT)March 6, 2025 | marketbeat.comIO Biotech, Inc. (NASDAQ:IOBT) Sees Large Decrease in Short InterestMarch 4, 2025 | marketbeat.comIO Biotech Reports 2024 Business HighlightsMarch 4, 2025 | globenewswire.comIO Biotech (IOBT) to Release Quarterly Earnings on TuesdayFebruary 25, 2025 | marketbeat.comIO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO ConferenceFebruary 23, 2025 | globenewswire.comIO Biotech to Present at the 45th Annual Cowen Health Care ConferenceFebruary 20, 2025 | globenewswire.comIO Biotech (NASDAQ:IOBT) Shares Up 4.2% - What's Next?February 19, 2025 | marketbeat.comIO Biotech announces publication of preclinical data on IO112February 4, 2025 | markets.businessinsider.comIO Biotech advances cancer vaccine candidate IO112February 4, 2025 | msn.comIO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine CandidateFebruary 4, 2025 | globenewswire.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest UpdateJanuary 28, 2025 | marketbeat.comJefferies maintains IO Biotech Buy rating, $8 target on PFS hopesJanuary 28, 2025 | msn.comIO Biotech completes enrollment in Phase 2 trial of IO102-IO103January 10, 2025 | markets.businessinsider.comIO Biotech Completes Phase 2 Enrollment Ahead Of Schedule For IO102-IO103 Cancer Vaccine TrialJanuary 10, 2025 | markets.businessinsider.comIO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck CancerJanuary 9, 2025 | globenewswire.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest Up 210.5% in DecemberDecember 26, 2024 | marketbeat.comIO Biotech, Inc. (NASDAQ:IOBT) CEO Acquires $10,125.00 in StockDecember 23, 2024 | marketbeat.comIO Biotech secures up to €57.5 million in debt financing from the European Investment BankDecember 20, 2024 | globenewswire.com Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Email Address IOBT Media Mentions By Week IOBT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IOBT News Sentiment▼0.000.58▲Average Medical News Sentiment IOBT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IOBT Articles This Week▼01▲IOBT Articles Average Week Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Eton Pharmaceuticals News Today Rezolute News Today CryoPort News Today Erasca News Today Vigil Neuroscience News Today Checkpoint Therapeutics News Today Tectonic Therapeutic News Today Solid Biosciences News Today Arcturus Therapeutics News Today MBX Biosciences News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IOBT) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IO Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.